January 21, 2010 β The Federal Patent Court in Munich, Germany upheld the validity of Edward Lifesciences' patent for transcatheter valve technology and dismissed invalidity claims by competitor CoreValve.
January 20, 2010 - Advanced breast imaging capabilities added elastography to the list, fused MR/CT image data combined with angiography navigation systems to guide percutaneous oncology, and 3.0 Tesla MR debut at the 2009 Radiological Society of North America (RSNA).
January 20, 2010 - The IHE 2010 North America Connectathon demonstrated the efficacy of electronic health record system connectivity and interoperable exchange of patient health data with standards-based systems.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
January 20, 2010 - Nearly $1 million of medical equipment and supplies donated by a leading medical manufacturer is being shipped today to Haitia for a team of Caritas Christi clinicians headed to Sacre Coeur Hospital, in Milot, Haiti, north of Port-au-Prince, to use to treat victims of the recent earthquake.
January 20, 2010 - The first FDA-cleared contrast imaging agent for use with a magnetic resonance angiography (MRA) indication to evaluate aortoiliac occlusive disease (AIOD) and suspected peripheral vascular disease enters the U.S. market today.
January 20, 2010 β The balloon material of the new REEF HP PTA Balloon Catheter was created for use in peripheral high-pressure dilatation procedures, especially to treat hard-to-dilate lesions. The balloon received FDA 510(k) clearance this week.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
January 20, 2010 β A new contrast-imaging agent for use with magnetic resonance angiography (MRA) is being launched this week in the United States. ABLAVAR (gadofosveset trisodium) is the first MRA injectable imaging agent used to evaluate aortoiliac occlusive disease (AIOD) in adults with known or suspected peripheral vascular disease (PVD).
January 20, 2010 β The FDA granted 510(k) market clearance for the NUVANT Mobile Cardiac Telemetry (MCT) System for the detection of nonlethal arrhythmias.
January 20, 2010 β LDL is not the only "bad cholesterol" according to a new study. A lipoprotein in the bloodstream called Lp(a) can also be labeled "bad cholesterol," according to the study Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease, recently published in the New England Journal Of Medicine.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
January 19, 2010 β A new simulator released today provides physicians with an opportunity to practice transcatheter heart valve implantation using a new module for the ANGIO Mentor simulator β the Percutaneous Aortic Valve Replacement Module.
January 19, 2010 β Final planning is in progress for a study of ultrasound-accelerated thrombolysis to treat pulmonary embolisms β the ULTrasound Accelerated ThrombolysIs of PulMonAry Embolism (ULTIMA) Study.
January 19, 2010 β A family of cardiovascular research products used to assess cardiac performance and hemodynamics, both in vivo and in vitro was launched today by iWorks.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
January 19, 2010 β While computed tomography (CT) is a crucial medical imaging tool in diagnosing illness and disease in children, there is always a concern over the amount of radiation dose a pediatric patient receives. Medical institutions, such as St. Louis Childrenβs Hospital, in St.
January 18, 2010 β A federal judge dismissed a lawsuit filed by the American College of Cardiology (ACC) against the Department of Health and Human Services (HHS) to prevent drastic reimbursement cuts. The reduction in payments began Jan. 1.
January 18, 2010 β A 10-year follow-up of patients with implantable cardioverter defibrillators (ICDs) will determine long-term outcomes of ICD therapy in heart failure patients.